Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

Application of Fluorescence Lifetime Imaging in Cancer Diagnosis

Application of Fluorescence Lifetime Imaging in Skin Cancer Diagnosis

Deep Learning Model Utilizing Fluorescence Lifetime Imaging Microscopy and Confidence Learning for Predicting Endometrial Cancer Risk

Early Detection of Cervical Cancer by Fluorescence Lifetime Imaging Microscopy Combined with Unsupervised Machine Learning

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Progression in Near-Infrared Fluorescence Imaging Technology for Lung Cancer Management

Recent advances in small-molecule fluorescent probes for diagnosis of cancer cells/tissues

Autofluorescence Imaging and Spectroscopy of Human Lung Cancer

Fluorescence intensity and lifetime imaging of lipofuscin-like autofluorescence for label-free predicting clinical drug response in cancer

The Application of Nucleic Acid Probe–Based Fluorescent Sensing and Imaging in Cancer Diagnosis and Therapy

Accurate Fluorescence Diagnosis of Cancer Based on Sequential Detection of Hydrogen Sulfide and pH

Detecting benign uterine tumors by autofluorescence lifetime imaging microscopy through adjacent healthy cervical tissues

Research progress of organic fluorescent probes for lung cancer related biomarker detection and bioimaging application

Application of Intelligent Response Fluorescent Probe in Breast Cancer

Application of Nanoparticles-Based Chemiluminescence in Diagnosis and Treatment of Inflammation and Tumor

Light-field tomographic fluorescence lifetime imaging microscopy

Frontiers in Fluorescence imaging: Tools for the In-Situ Sensing of Disease Biomarkers

Fibre-based fluorescence-lifetime imaging microscopy: a real-time biopsy guidance tool for suspected lung cancer

Applications of machine learning in time-domain fluorescence lifetime imaging: a review

Measuring Metabolic Changes in Cancer Cells Using Two‐Photon Fluorescence Lifetime Imaging Microscopy and Machine‐Learning Analysis

Fluorescence Lifetime Imaging of the Skin